|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 239/70 | |
| C07D 401/12 | |||
| C07D 403/04 | |||
| C07D 403/12 | |||
| C07D 407/12 | |||
| C07D 409/12 | |||
| C07D 409/14 | |||
| A61K 31/517 | |||
| A61P 35/00 |
| (11) | Number of the document | 2399909 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11166123.7 |
| Date of filing the European patent application | 2007-07-05 | |
| (97) | Date of publication of the European application | 2011-12-28 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 818718 P | 2006-07-06 | US |
| (72) |
Mitchell, Ian, S., US
Blake, James, F., US
Xu, Rui, US
Kallan, Nicholas, C., US
Xiao, Dengming, US
Spencer, Keith, Lee, US
Bencsik, Josef, R., US
Liang, Jun, US
Safina, Brian, US
Zhang, Birong, US
Chabot, Christine, US
Do, Steven, US
Wallace, Eli, W., US
Banka, Anna, L., US
Schlachter, Stephen, T., US
|
| (73) |
Array Biopharma, Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
Genentech, Inc., 1 DNA Way, South San Francisco CA 94080-4490, US |
| (54) | Hydroxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors |
| Hydroxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors |